Name | (S)-α,α-Diphenyl-3-pyrrolidineacetamide |
---|---|
Synonyms |
(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile
(S)-alpha,alpha-Diphenyl-3-pyrrolidineacetamide (S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetamide 2,2-Diphenyl-2-[(3S)-3-pyrrolidinyl]acetamide 3-Pyrrolidineacetamide, α,α-diphenyl-, (3S)- (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile (S)-(+)-Alfa,Alfa-Diphenyl-3-Pyrrolidine acetamide (S)-3-(1-cyano-1,1-diphenylmethyl)pyrrolidine (S)-3-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine 2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetonitrile 3-(S)-(+)-(cyano-1,1-diphenylmethyl)-pyrrolidine 2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 488.5±45.0 °C at 760 mmHg |
Molecular Formula | C18H20N2O |
Molecular Weight | 280.364 |
Flash Point | 249.2±28.7 °C |
Exact Mass | 280.157562 |
PSA | 55.12000 |
LogP | 2.24 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.596 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933990090 |
~99% 133099-11-3 |
Literature: Theravance, Inc. Patent: US2005/277688 A1, 2005 ; Location in patent: Page/Page column 11 ; US 20050277688 A1 |
~19% 133099-11-3 |
Literature: MEDICHEM, S.A. Patent: WO2009/153649 A1, 2009 ; Location in patent: Page/Page column 11; 12 ; |
~97% 133099-11-3 |
Literature: Pramanik, Chinmoy; Bapat, Kiran; Chaudhari, Ashok; Tripathy, Narendra K.; Gurjar, Mukund K. Organic Process Research and Development, 2012 , vol. 16, # 10 p. 1591 - 1597 |
~65% 133099-11-3 |
Literature: AUSPEX PHARMACEUTICALS, INC. Patent: US2009/5431 A1, 2009 ; Location in patent: Page/Page column 32 ; US 20090005431 A1 |
Precursor 4 | |
---|---|
DownStream 3 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |